Cubist pharmaceuticals stock price

WebFeb 11, 2014 · Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Cubist Pharmaceuticals, Inc. (CBSTZ) … WebApr 6, 2024 · Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) issued its quarterly earnings results on Tuesday, February, 28th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.30. The company had revenue of $61.88 million for the quarter, compared to analysts' expectations of $47.18 million.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average …

WebDec 8, 2014 · News of the deal sent Cubist's share price surging by more than 34 percent, to $101.15, in premarket trading. Merck's stock price also rose more than 5 percent. WebApr 11, 2024 · 3 Wall Street research analysts have issued 1-year price objectives for Amphastar Pharmaceuticals' shares. Their AMPH share price forecasts range from $36.00 to $44.00. On average, they predict the company's share price to reach $40.75 in the next year. This suggests a possible upside of 3.2% from the stock's current price. how many hammers does thor have https://myorganicopia.com

Merck to buy Cubist Pharmaceuticals for $9.5 billion - CNBC

WebApr 12, 2024 · Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Rating)’s stock price traded up 6.3% during mid-day trading on Tuesday after Piper Sandler raised their price target on the stock from $49.00 ... WebApr 6, 2024 · 14 brokers have issued 1 year price objectives for Apellis Pharmaceuticals' shares. Their APLS share price forecasts range from $40.00 to $139.00. On average, they predict the company's share price to reach $78.40 in the next twelve months. This suggests that the stock has a possible downside of 0.5%. WebApr 11, 2024 · Cubist Systematic Strategies LLC now owns 40,323 shares of the biotechnology company’s stock valued at $2,092,000 after buying an additional 2,900 shares during the last quarter. Prudential... how about going to the movies

RadNet (NASDAQ:RDNT) Hits New 1-Year High at $27.59

Category:Cubist Pharmaceuticals Stock Forecast, Price & News (NASDAQ:CBST)

Tags:Cubist pharmaceuticals stock price

Cubist pharmaceuticals stock price

Better Buy: Cubist Pharmaceuticals, Inc. vs. Durata Therapeutics, …

WebJun 27, 2011 · Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Charles Laranjeira has joined the company as Senior Vice President of Technical Operations. Mr. Laranjeira oversees all facets of Cubist's technical operations, including global manufacturing, quality, supply chain, and distribution. WebSep 5, 2013 · Cubist Pharmaceuticals, Inc. today announced the pricing of $700 million aggregate principal amount of convertible senior unsecured notes that will be issued in …

Cubist pharmaceuticals stock price

Did you know?

WebJan 21, 2015 · Merck announced the successful completion of the tender offer for all of the outstanding shares of common stock of Cubist Pharmaceuticals, Inc. at a purchase price of $102.00 per share. Contacts

WebDec 19, 2013 · /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports... WebMar 23, 2024 · CUBIST PHARMACEUTICALS INC (NASDAQ:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CUBIST PHARMACEUTICALS …

WebJun 30, 2014 · Trius was a stock which I first recommended in May of 2012, a little over one year before it was taken over by Cubist. In a series of reports that are available on my … WebDec 31, 2013 · On December 26, 2013, Cubist Pharmaceuticals Inc.'s (Cubist) stock declined 0.39%, ending the day's trading session at $66.94. Over the previous three trading sessions, shares of Cubist...

WebApr 9, 2024 · Cantor Fitzgerald upped their target price on shares of ACADIA Pharmaceuticals from $28.00 to $33.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 14th.

WebMar 7, 2011 · Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that its Board of Directors has appointed Kenneth M. (Ken) Bate as non-executive Chair of the Board effective immediately. Mr. Bate has been serving as Lead Director of the Cubist Board since June of 2006. Cubist has had a long-standing commitment to the clear … how about hannahWebNov 3, 2015 · Branch of CUBIST PHARMACEUTICALS LLC (Delaware (US)) Controlling Company. MERCK & CO., INC. Registered Address. WEYSTRASSE 20. 6000 LUCERNE 6 SWITZERLAND. United States. Inactive Directors / Officers. C T … how about go shoppingWebApr 14, 2024 · FaZe Holdings Inc. ( NASDAQ:FAZE – Get Rating )’s stock price shot up 6.3% on Thursday . The company traded as high as $0.52 and last traded at $0.51. 384,459 shares changed hands during ... how many hammer curls should i doWebJul 14, 2024 · Cubist Pharmaceuticals Inc (NASDAQ:CBST) issued its earnings results on Tuesday, October, 21st. The biopharmaceutical company reported $0.58 earnings per … Their NVAX share price forecasts range from $27.00 to $168.00. On average, … What is Intercept Pharmaceuticals' stock price forecast for 2024? 7 equities … The current CBST price target is $0.00. Learn why top analysts are making this … how about having some fruitWebJun 30, 2014 · Trius was a stock which I first recommended in May of 2012, a little over one year before it was taken over by Cubist. In a series of reports that are available on my website, I projected that Sivextro could achieve worldwide sales of $1 billion in 2024. how about halaraWebApr 12, 2024 · Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Rating) shot up 6.3% on Tuesday after Piper Sandler raised their price target on the stock from $49.00 to $54.00. Piper Sandler currently has ... how about grammarWebCompany profile page for Cubist Pharmaceuticals LLC including stock price, company news, press releases, executives, board members, and contact information how many hamsters in the world